Navigate MOH (KKM), NPRA, and MDA frameworks with precision and speed. We provide tailored enterprise solutions for seamless market access.
ARCI is Malaysia's premier regulatory consultancy, specializing in National Pharmaceutical Regulatory Agency (NPRA) drug registration, cosmetic notification, and Medical Device Authority (MDA) compliance. We provide end-to-end market access solutions for local and international healthcare enterprises seeking approval from the Ministry of Health (MOH/KKM) Malaysia.
ARCI provides specialized regulatory, compliance, and insight solutions for businesses seeking product approvals in Malaysia. Our deep expertise in NPRA, FSQD, MDA, and GDPMD frameworks ensures your path to market is clear, compliant, and efficient.
Years of Market Experience
Comprehensive registration and compliance solutions tailored for every product category in the Malaysian market.
Strategic guidance for NCEs and biologicals ensuring full NPRA compliance and successful market entry.
Learn More →Efficient notification services for cosmetic products via the Quest3+ system with rapid processing.
Learn More →Streamlined approval pathways for scheduled poisons and OTC generics with comprehensive support.
Learn More →Ensuring safety and quality compliance for health and dietary supplements in the Malaysian market.
Learn More →Full lifecycle support for MDA registration and GDPMD compliance for all device classifications.
Learn More →Classification and compliance advisory for Food-Drug Interphase (FDI) products and health food labels.
Learn More →